REGEN-COV Trademark

Trademark Overview


On Wednesday, October 28, 2020, a trademark application was filed for REGEN-COV with the United States Patent and Trademark Office. The USPTO has given the REGEN-COV trademark a serial number of 90284296. The federal status of this trademark filing is REGISTERED as of Tuesday, September 21, 2021. This trademark is owned by Regeneron Pharmaceuticals, Inc.. The REGEN-COV trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceutical preparations for treatment or prevention of COVID-19, coronavirus disease, and respiratory diseases and disorders; antivirals for treatment or prevention of COVID-19, coronavirus disease, and respiratory diseases and disorders
regen-cov

General Information


Serial Number90284296
Word MarkREGEN-COV
Filing DateWednesday, October 28, 2020
Status700 - REGISTERED
Status DateTuesday, September 21, 2021
Registration Number6495144
Registration DateTuesday, September 21, 2021
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, December 22, 2020

Trademark Statements


Goods and ServicesPharmaceutical preparations for treatment or prevention of COVID-19, coronavirus disease, and respiratory diseases and disorders; antivirals for treatment or prevention of COVID-19, coronavirus disease, and respiratory diseases and disorders

Classification Information


International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes005, 006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateTuesday, November 17, 2020
Primary Code005
First Use Anywhere DateMonday, May 31, 2021
First Use In Commerce DateMonday, May 31, 2021

Trademark Owner History


Party NameRegeneron Pharmaceuticals, Inc.
Party Type30 - Original Registrant
Legal Entity Type03 - Corporation
AddressTarrytown, NY 10591

Party NameRegeneron Pharmaceuticals, Inc.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressTarrytown, NY 10591

Party NameRegeneron Pharmaceuticals, Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressTarrytown, NY 10591

Trademark Events


Event DateEvent Description
Thursday, March 7, 2024COUNTERCLAIM OPP. NO. 999999
Thursday, July 14, 2022TEAS CHANGE OF CORRESPONDENCE RECEIVED
Thursday, July 14, 2022ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Thursday, July 14, 2022TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Tuesday, September 21, 2021REGISTERED-PRINCIPAL REGISTER
Tuesday, August 17, 2021NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
Monday, August 16, 2021ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
Wednesday, July 28, 2021STATEMENT OF USE PROCESSING COMPLETE
Friday, July 16, 2021USE AMENDMENT FILED
Wednesday, July 28, 2021CASE ASSIGNED TO INTENT TO USE PARALEGAL
Friday, July 16, 2021TEAS STATEMENT OF USE RECEIVED
Tuesday, July 6, 2021NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Friday, July 2, 2021SOU EXTENSION 1 GRANTED
Friday, July 2, 2021SOU EXTENSION 1 FILED
Friday, July 2, 2021SOU TEAS EXTENSION RECEIVED
Tuesday, February 16, 2021NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, December 22, 2020OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, December 22, 2020PUBLISHED FOR OPPOSITION
Wednesday, December 2, 2020NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, November 17, 2020APPROVED FOR PUB - PRINCIPAL REGISTER
Tuesday, November 17, 2020ASSIGNED TO EXAMINER
Tuesday, November 17, 2020NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Monday, November 16, 2020PETITION TO DIRECTOR GRANTED
Thursday, November 12, 2020ASSIGNED TO PETITION STAFF
Monday, November 2, 2020TEAS PETITION TO DIRECTOR RECEIVED
Sunday, November 1, 2020NEW APPLICATION ENTERED